OMMA says med-portal has stabilized and QA lab accreditation is progressing

Director Adria Berry told the council the agency continues to stabilize the online med-portal and is processing applications after earlier delays; she reported roughly 30–36 day turnaround for commercial renewals, same-day processing for credentials and transport agents, and an eight-day turnaround for patient applications.

Berry said OMMA has launched an administrative actions tab to make filings and court-docket information easier to track and that the agency will add a labs tab to publish inspection and laboratory validation data.

Bobby Grambling, OMMA’s chief science officer (identified in the transcript as 'Bobby Grama'), gave a technical update on the QA lab and testing validation timetable. He said the QA lab has attained accreditation for potency and flower testing and that ANAB will update the agency soon about pesticide accreditation for flower and potency in oil. He outlined the validation schedule: terpenes, water activity and filth/form materials validation are expected by March; heavy metals, mycotoxins and residual-solvent validations are projected for late April; and microbial validation is anticipated in May. He also said OMMA’s inspection and reporting timelines have improved and that 12 cases related to labs were filed in 2024–25 with one lab license revoked for noncompliance.

Berry said OMMA has been able to hold vendors accountable for the med-portal rollout and that staff are working directly with applicants who experience trouble. She asked council members to review the agency’s posted budget hearing materials and said the agency requested a flat budget this year.